Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
9 Years Aggregate
CFO
$-11.86 Mln
EBITDA
$-17.47 Mln
Net Profit
$-30.88 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Nutriband Inc. Warrant (NTRBW)
| -62.6 | 71.9 | -33.2 | -59.9 | -1.9 | -- | -- |
|
BSE Sensex
| -11.7 | -4.8 | 1.1 | -8.2 | 3.9 | 5.1 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Nutriband Inc. Warrant (NTRBW)
| 15.0 | 284.6 | -88.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Nutriband Inc. Warrant (NTRBW)
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. Its lead product is AVERSA Fentanyl, an abuse deterrent fentanyl patch for the treatment of chronic pain. The company also develops AVERSA buprenorphine... and AVERSA methylphenidate. It has a commercial development and clinical supply agreement for Aversa Fentanyl with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida. Read more
-
Founder, President, Company Secretary & Executive Chairman of the Board
Mr. Serguei Melnik
-
Founder, President, Company Secretary & Executive Chairman of the Board
Mr. Serguei Melnik
-
Headquarters
Orlando, FL
-
Website
FAQs for Nutriband Inc. Warrant (NTRBW)
What is the current share price of Nutriband Inc Warrant (NTRBW) Today?
The share price of Nutriband Inc Warrant (NTRBW) is $0.60 (NASDAQ) as of 11-Sep-2026 15:56 EDT. Nutriband Inc Warrant (NTRBW) has given a return of -1.94% in the last 3 years.
What is the current PB & PE ratio of Nutriband Inc Warrant (NTRBW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2026 |
-- |
-- |
2025 |
-- |
-- |
2024 |
-- |
-- |
2023 |
-- |
-- |
2022 |
-- |
-- |
What is the 52 Week High and Low of Nutriband Inc Warrant (NTRBW)?
The 52-week high and low of Nutriband Inc Warrant (NTRBW) are Rs 2.99 and Rs 0.17 as of 14-Sep-2026.
What is the market cap of Nutriband Inc Warrant (NTRBW)?
Nutriband Inc Warrant (NTRBW) has a market capitalisation of -- as on 11-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Nutriband Inc Warrant (NTRBW)?
Before investing in Nutriband Inc Warrant (NTRBW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.